A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-015-2688-9
Published Online: 2015-01-29
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Choi, Dae Ro
Yoon, Sang Nam
Kim, Hyeong Su
Kim, Jung Han
Kim, Kwang Yong
Kim, Byung Chun
Choi, Young Kyun
Kim, Jin Bae
Han, Boram
Song, Hun Ho
Zang, Dae Young
Text and Data Mining valid from 2015-01-29